Kestra Medical Technologies (KMTS) Gross Profit (2024 - 2026)

Kestra Medical Technologies (KMTS) has 3 years of Gross Profit data on file, last reported at $12.9 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $12.9 million, up 97.13% year-over-year; the trailing twelve-month figure through Jan 2026 was $40.8 million (up 127.07% YoY), and the FY2025 annual result was $24.2 million, up 6587.85% from the prior year.
• Gross Profit advanced to $12.9 million in Q1 2026 per KMTS's latest filing, from $11.4 million in the prior quarter.
• Over five years, Gross Profit peaked at $12.9 million in Q1 2026 and troughed at $880000.0 in Q1 2024.
• A 3-year average of $6.6 million and a median of $6.5 million in 2025 frame the typical range for Gross Profit.
• On a YoY basis, Gross Profit climbed as much as 643.98% in 2025 and fell as far as 95.95% in 2025.
• A 3-year view of Gross Profit shows it stood at $5.8 million in 2024, then surged by 95.95% to $11.4 million in 2025, then advanced by 12.97% to $12.9 million in 2026.
• Business Quant data shows KMTS's Gross Profit at $12.9 million in Q1 2026, $11.4 million in Q4 2025, and $8.9 million in Q3 2025.